Efficacy of Unilateral Greater Occipital Nerve Block in Migraine Management: A Focused Approach for Targeted Relief

Ceyhun Sayman; Buse Hasırcı Bayır; Gizem Gürsoy; Kerim Şahin; Yılmaz Çetinkaya

Makale detayları

Efficacy of Unilateral Greater Occipital Nerve Block in Migraine Management: A Focused Approach for Targeted Relief

Yazarlar:

Ceyhun Sayman | Buse Hasırcı Bayır | Gizem Gürsoy | Kerim Şahin | Yılmaz Çetinkaya

Yayıncı:

Alanya Alaaddin Keykubat Üniversitesi

Ana Başlıklar:

Klinik Tıp Bilimleri (Diğer)

Dergi:

Acta Medica Alanya Vol.9 Issue 1, pp.4-9

Belge Tipi:

Makale

Yayın Tarihi:

1/2025

Belge Dili:

İngilizce

Document ID (Org No.):

2001344671

pISSN:

2587-0319

Anahtar kelimeler:

Özet:

 Aim: Migraine is one of the most common and disabling neurological disorders, causing a great deal of suffering both from an individual perspective and a public health point of view. Patients often suffer from either lack of efficacy or adverse reactions of oral treatments. The Greater occipital nerve GON block has recently come forward as a potentially useful choice for migraines. This study, therefore, assessed unilateral GON block to treat migraine. Methods: A total of 35 patients with migraine were included in this prospective study. The frequency, duration, pain severity and analgesic consumption of headaches were evaluated at baseline and 1 week, 1 month and 3 months post-treatment in GON block. The primary outcome measures included changes in the number of migraine attacks, duration, and the severity of pain using a visual analogue scale VAS. Results: A substantial decrease was shown in the median number of migraine attacks, from 12 at baseline to 3 at month 3 p0.007. The mean duration of migraine attacks reduced from 12 hours at baseline to 3 hours at month 3 p  0.0001, and the mean VAS score was improved from 10 at baseline to 4 at month 3 p  0.0001. There was also a significant reduction in analgesic use from 12 at baseline to 2 doses per month p0.005. Conclusion: Our results show that unilateral GON block is an efficient and well-tolerated intervention for migraine patients, significantly decreasing headache frequency, intensity and duration.

 Aim: Migraine is one of the most common and disabling neurological disorders, causing a great deal of suffering both from an individual perspective and a public health point of view. Patients often suffer from either lack of efficacy or adverse reactions of oral treatments. The Greater occipital nerve GON block has recently come forward as a potentially useful choice for migraines. This study, therefore, assessed unilateral GON block to treat migraine. Methods: A total of 35 patients with migraine were included in this prospective study. The frequency, duration, pain severity and analgesic consumption of headaches were evaluated at baseline and 1 week, 1 month and 3 months post-treatment in GON block. The primary outcome measures included changes in the number of migraine attacks, duration, and the severity of pain using a visual analogue scale VAS. Results: A substantial decrease was shown in the median number of migraine attacks, from 12 at baseline to 3 at month 3 p0.007. The mean duration of migraine attacks reduced from 12 hours at baseline to 3 hours at month 3 p  0.0001, and the mean VAS score was improved from 10 at baseline to 4 at month 3 p  0.0001. There was also a significant reduction in analgesic use from 12 at baseline to 2 doses per month p0.005. Conclusion: Our results show that unilateral GON block is an efficient and well-tolerated intervention for migraine patients, significantly decreasing headache frequency, intensity and duration.

 Aim: Migraine is one of the most common and disabling neurological disorders, causing a great deal of suffering both from an individual perspective and a public health point of view. Patients often suffer from either lack of efficacy or adverse reactions of oral treatments. The Greater occipital nerve GON block has recently come forward as a potentially useful choice for migraines. This study, therefore, assessed unilateral GON block to treat migraine. Methods: A total of 35 patients with migraine were included in this prospective study. The frequency, duration, pain severity and analgesic consumption of headaches were evaluated at baseline and 1 week, 1 month and 3 months post-treatment in GON block. The primary outcome measures included changes in the number of migraine attacks, duration, and the severity of pain using a visual analogue scale VAS. Results: A substantial decrease was shown in the median number of migraine attacks, from 12 at baseline to 3 at month 3 p0.007. The mean duration of migraine attacks reduced from 12 hours at baseline to 3 hours at month 3 p  0.0001, and the mean VAS score was improved from 10 at baseline to 4 at month 3 p  0.0001. There was also a significant reduction in analgesic use from 12 at baseline to 2 doses per month p0.005. Conclusion: Our results show that unilateral GON block is an efficient and well-tolerated intervention for migraine patients, significantly decreasing headache frequency, intensity and duration.

 Amaç: Migren hem bireysel açıdan hem de halk sağlığı perspektifinden büyük acılara neden olan en yaygın ve engelleyici nörolojik bozukluklardan biridir. Hastalar, genellikle ağızdan alınan tedavilerin ya etkinlik eksikliği ya da yan etkileri nedeniyle sıkıntı yaşamaktadır. Son zamanlarda, Büyük oksipital sinir greater occipital nerve- GON blokajı migren tedavisinde potansiyel bir seçenek olarak öne çıkmıştır. Bu çalışma, bu nedenle, migren tedavisinde tek taraflı GON blokajını değerlendirmiştir. Yöntem: Bu prospektif çalışmaya toplam 35 migren hastası dahil edilmiştir. Başlangıçta ve GON blokajı tedavisinden sonra 1 hafta, 1 ay ve 3 ayda baş ağrılarının sıklığı, süresi, ağrı şiddeti ve analjezik kullanımını değerlendirilmiştir. Birincil sonuç ölçütleri, migren ataklarının sayısındaki, süresindeki ve görsel analog skala visual analogue scale- VAS kullanılarak ölçülen ağrı şiddetindeki değişiklikleri içermektedir. Bulgular: Migren ataklarının ortanca sayısının başlangıçta 12den 3. aya kadar üçe düştüğü görülmüş ve anlamlı bir azalma gösterilmiştir p0.007. Migren ataklarının başlangıçtaki ortalama süresi 12 saatten 3. ayda 3 saate düşmüş p  0.0001 ve başlangıçtaki ortalama VAS skoru 10dan 3. ayda 4e iyileşmiştir p  0.0001. Ayrıca, alınan analjezik ilaç sayısı da başlangıçtaki 12 iken, 3. ayda 2ye gerilemiştir p0.005. Sonuç: Sonuçlarımız, migren hastaları için tek taraflı GON blokajının, baş ağrısı sıklığını, şiddetini ve süresini önemli ölçüde azaltan etkili ve iyi tolere edilen bir müdahale olduğunu göstermektedir.

Makale detayları

Efficacy of Unilateral Greater Occipital Nerve Block in Migraine Management: A Focused Approach for Targeted Relief

Yazarlar:

Ceyhun Sayman | Buse Hasırcı Bayır | Gizem Gürsoy | Kerim Şahin | Yılmaz Çetinkaya

Yayıncı:

Alanya Alaaddin Keykubat Üniversitesi

Ana Başlıklar:

Klinik Tıp Bilimleri (Diğer)

Dergi:

Acta Medica Alanya Vol.9 Issue 1, pp.4-9

Belge Tipi:

Makale

Yayın Tarihi:

1/2025

Belge Dili:

İngilizce

Document ID (Org No.):

2001344671

pISSN:

2587-0319

Great Occipital Block

Migraine

VASMigren

Büyük oksipital sinir blokajı (GON)

Vizüel analog skala (VAS)

Sayı

Makale detayları

Efficacy of Unilateral Greater Occipital Nerve Block in Migraine Management: A Focused Approach for Targeted Relief

Yazarlar: Ceyhun Sayman | Buse Hasırcı Bayır | Gizem Gürsoy | Kerim Şahin | Yılmaz Çetinkaya

Yayıncı: Alanya Alaaddin Keykubat Üniversitesi

Ana Başlıklar: Klinik Tıp Bilimleri (Diğer)

Dergi: Acta Medica Alanya Vol.9 Issue 1, pp.4-9

Belge Tipi: Makale

Yayın Tarihi: 1/2025

Belge Dili: İngilizce

Document ID (Org No.): 2001344671

pISSN: 2587-0319

Great Occipital Block

Migraine

VASMigren

Büyük oksipital sinir blokajı (GON)

Vizüel analog skala (VAS)

Sayı

Yazarlar:

Ceyhun Sayman | Buse Hasırcı Bayır | Gizem Gürsoy | Kerim Şahin | Yılmaz Çetinkaya

Yayıncı:

Alanya Alaaddin Keykubat Üniversitesi

Ana Başlıklar:

Klinik Tıp Bilimleri (Diğer)

Dergi:

Acta Medica Alanya Vol.9 Issue 1, pp.4-9

Belge Tipi:

Makale

Yayın Tarihi:

1/2025

Belge Dili:

İngilizce

Document ID (Org No.):

2001344671

pISSN:

2587-0319